Screening of an FDA-approved compound library identifies apigenin for the treatment of myocardial injury
International Journal of Biological Sciences · 2023
DOI: 10.7150/ijbs.85204 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2023. Verfasst von Haixia Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China. Hauptthemen laut MEDLINE: Apigenin, Cardiomyopathies. Die Arbeit wurde bisher 21-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine, Beijing, 100000, China.
- Beijing University of Chinese Medicine, Beijing, 100029, China.
- Zhejiang Tongde Hospital, Hangzhou, 310012, China.
- Wenzhou TCM Hospital of Zhejiang Chinese Medical University, Wenzhou, 325000, China.
- School of Medicine, Southern University of Science and Technology (SUSTech), Shenzhen, Guangdong, China.
Zitieren
APA
Li, H., Chen, D., Zhang, X., Chen, M., Zhi, Y., Cui, W., Li, S., Xu, F., Tan, Y., Zhou, H., Chang, X., & Chen, H. (2023). Screening of an FDA-approved compound library identifies apigenin for the treatment of myocardial injury. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.85204
Vancouver
Li H, Chen D, Zhang X, Chen M, Zhi Y, Cui W, et al. Screening of an FDA-approved compound library identifies apigenin for the treatment of myocardial injury. International Journal of Biological Sciences. 2023. doi:10.7150/ijbs.85204
BibTeX
@article{Li2023,
author = {Li, Haixia and Chen, Dong and Zhang, Xiaoqin and Chen, Mingxian and Zhi, Yinghao and Cui, Weilu and Li, Shanshan and Xu, Fan and Tan, Ying and Zhou, Hao and Chang, Xing and Chen, Hengwen},
title = {Screening of an FDA-approved compound library identifies apigenin for the treatment of myocardial injury},
journal = {International Journal of Biological Sciences},
year = {2023},
doi = {10.7150/ijbs.85204}
}
EUVIMED